Haleon plc
NYSE:HLNDrug Manufacturers - Specialty & Generic
+$0.08 today
- Market cap
- $39.85B
- Beta
- 0.25
- P/E (TTM)
- 29.2
- EPS (TTM)
- $0.11
- Dividend yield
- 2.13%
Volume 19.46M
Average 8.79M
HLN Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Haleon plcNYSE: HLN
Common Stock · Q4 FY2025 · quarter ended Dec 2025
Common stock broadly unchanged from a year ago
Common stock stood at £89.84M at the end of Q4 FY2025, down 1.3% from a year earlier. Over 3 fiscal years it compounded at -0.8% a year.
Context
- Common stock amounted to 0.3% of total assets at the end of Q4 FY2025, unchanged from a year earlier.
- Common stock increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps falling in the next quarterly balance sheet after a -1.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
GBP · from the balance sheet
- Latest · FY2025
- 89.84M GBP
- Year-over-year change
- -1.3%
- 4-year CAGR
- +207.9%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 89.84M | -1.3% |
| FY2024 | 2024-12-31 | 91M | -1.1% |
| FY2023 | 2023-12-31 | 92M | +0.0% |
| FY2022 | 2022-12-31 | 92M | +9100.0% |
| FY2021 | 2021-12-31 | 1M | — |
Common Stock vs competitors
How HLN compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -1.3% is the 4th highest of 6, against a peer median of +0.0%.
- Common stock amounts to 0.3% of total assets for HLN, versus a peer median of 3.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $6.54B USD | -1.9% | -1.6% | 86.0% | |
| Sep 2026 | $1.47B USD | +0.0% | +0.0% | 8.8% | |
| Jun 2026 | £1.34B GBP | -27.5% | -0.0% | 2.2% | |
| Sep 2026 | $294M USD | +0.1% | +0.0% | 3.1% | |
| Dec 2025 | £89.84M GBP | -1.3% | -0.8% | 0.3% | |
| Sep 2026 | $19M USD | +0.0% | — | 0.1% | |
| Peer median (excluding HLN) | — | +0.0% | -0.0% | 3.1% | |
Competitors are the stored peer set for HLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 414M | 684M | 1.04B | 2.2B | 1.32B |
| Short-term Investments | 0 | 0 | 0 | 55M | 0 |
| Net Receivables | 3.83B | 1.49B | 1.35B | 1.9B | 2.12B |
| Inventory | 951M | 1.35B | 1.41B | 1.19B | 1.02B |
| Other Current Assets | 5M | 434M | 907M | 223M | 77.86M |
| Total Current Assets | 5.25B | 4.06B | 4.82B | 5.72B | 4.54B |
| Property, Plant & Equipment (Net) | 1.66B | 1.9B | 1.9B | 1.92B | 1.99B |
| Goodwill | 8.25B | 8.4B | 8.32B | 8.2B | 8.13B |
| Intangible Assets | 18.95B | 20.04B | 18.54B | 18.01B | 17.49B |
| Long-term Investments | 23M | 44M | 65M | 82M | 75.87M |
| Tax Assets | 312M | 220M | 0 | 0 | 288.49M |
| Other Non-current Assets | 8M | 157M | 415M | 383M | 104.82M |
| Total Non-current Assets | 29.2B | 30.76B | 29.24B | 28.6B | 28.03B |
| Total Assets | 34.45B | 34.82B | 34.06B | 34.32B | 32.57B |
| Account Payables | 1.58B | 1.84B | 1.86B | 1.97B | 3.72B |
| Short-term Debt | 874M | 393M | 608M | 1.44B | 834.53M |
| Tax Payables | 237M | 210M | 288M | 286M | 0 |
| Deferred Revenue | 11M | 23M | 0 | 0 | 33.94M |
| Other Current Liabilities | 1.43B | 1.61B | 1.57B | 693M | 17.88M |
| Total Current Liabilities | 4.24B | 4.37B | 4.64B | 5.81B | 4.92B |
| Long-term Debt | 1M | 9.89B | 8.71B | 8.54B | 7.66B |
| Deferred Tax Liabilities | 3.36B | 3.6B | 3.49B | 3.35B | 3.22B |
| Deferred Revenue (Non-current) | 281M | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 289M | 384M | 424M | 311M | 217.62M |
| Total Non-current Liabilities | 3.73B | 13.99B | 12.69B | 12.28B | 11.19B |
| Total Liabilities | 7.97B | 18.36B | 17.33B | 18.09B | 16.12B |
| Common Stock | 1M | 92M | 92M | 91M | 89.84M |
| Retained Earnings | 37.99B | 26.73B | 27.47B | 27.27B | 16.13B |
| Accumulated OCI | (11.63B) | 1.2B | (10.96B) | 761.46M | 335.41M |
| Other Stockholders Equity | 0 | (11.69B) | 0 | (11.08B) | 0 |
| Minority Interest | 125M | 126M | 123M | 58M | 58.9M |
| Total Equity | 26.48B | 16.46B | 16.73B | 16.22B | 16.46B |
| Total Debt | 991M | 10.44B | 9.46B | 10.1B | 8.59B |
| Net Debt | 577M | 9.76B | 8.41B | 7.91B | 7.27B |
Haleon plc
NYSE:HLN
Intrinsic Alpha fair value
Locked
Current Price
$9.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.